MENU

PVLA Palvella Therapeutics Inc Forecast, Technical & Fundamental Analysis

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more

PVLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
PVLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PVLA is expected to report earnings to rise 47.50% to -176 cents per share on November 17

Palvella Therapeutics Inc PVLA Stock Earnings Reports
Q3'26
Est.
$-1.77
Q1'26
Missed
by $0.71
Q4'25
Beat
by $0.04
Q3'25
Beat
by $1.10
Q2'25
Beat
by $1.17
The last earnings report on May 07 showed earnings per share of -120 cents, missing the estimate of -49 cents. With 61.95K shares outstanding, the current market capitalization sits at 2.05B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JXX31.620.29
+0.94%
Janus Henderson Transformational Gr ETF
MILN46.620.26
+0.56%
Global X Millennials Consumer ETF
RFMZ13.150.06
+0.46%
RiverNorth Flexible Municipal Income Fund II
BKMI25.990.04
+0.15%
BNY Mellon Municipal Intermediate ETF
NCLO25.060.03
+0.12%
Nuveen AA-BBB CLO ETF

PVLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with VIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
-0.38%
VIR - PVLA
44%
Loosely correlated
+6.19%
DRMA - PVLA
42%
Loosely correlated
+2.90%
TRVI - PVLA
40%
Loosely correlated
-1.59%
ARQT - PVLA
38%
Loosely correlated
-1.07%
BEAM - PVLA
37%
Loosely correlated
+4.83%
More
Palvella Therapeutics (PVLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com